TWUAX | VIGIX | TWUAX / VIGIX | |
Total Expense Ratio | 1.12 | 0.04 | 2,800% |
Annual Report Gross Expense Ratio | 1.17 | 0.04 | 2,925% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | 6.657 | 12.380 | 54% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.2B | 324B | 8% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | 11.41 | 23.74 | 48% |
Returns for 3 years | 46.90 | 89.35 | 52% |
Returns for 5 years | 33.13 | 93.64 | 35% |
Returns for 10 years | 165.26 | 347.23 | 48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HNDL | 21.94 | 0.07 | +0.30% |
Strategy Shares Nasdaq 7 Handl™ ETF | |||
MCDS | 57.75 | N/A | N/A |
JPMorgan Fundamental Data Sci Md Cor ETF | |||
THTA | 15.01 | -0.01 | -0.06% |
SoFi Enhanced Yield ETF | |||
XPH | 47.26 | -0.04 | -0.08% |
SPDR® S&P Pharmaceuticals ETF | |||
DFAT | 58.83 | -0.10 | -0.17% |
Dimensional US Targeted Value ETF |